FGP
XRAY icon

Freestone Grove Partners’s Dentsply Sirona XRAY Stock Holding History

Freestone Grove Partners’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.6M Buy
+2,297,378
New +$28.7M 0.19% 176

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Freestone Grove Partners's XRAY Position: Q1 2026 in Review

Freestone Grove Partners opened a new position in Dentsply Sirona (XRAY) in Q1 2026: 2,297,378 shares worth $26.6M. The stake represents 0.19% of the portfolio and ranks #176 among its holdings.

382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Freestone Grove Partners held 2,297,378 shares of Dentsply Sirona worth $26.6M as of Q1 2026.
  • Dentsply Sirona was a new Freestone Grove Partners position in Q1 2026.
  • Dentsply Sirona made up 0.19% of Freestone Grove Partners's portfolio in Q1 2026, its #176 holding.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.